Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Unadjusted (Observed) and Case Mix-Adjusted Prevalence Rates for... | Download Table
PDF) FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG) | I. Varthalitis
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
Ioannis VARTHALITIS | Head of Department | 1st Medical Oncology Dept
